@prefix this: <
http://www.tkuhn.ch/bel2nanopub/RAdMqJ9hADroiUkAc5F6BSrDFzYy7uj7Q-ZeelZoj_zjw
> .
@prefix sub: <
http://www.tkuhn.ch/bel2nanopub/RAdMqJ9hADroiUkAc5F6BSrDFzYy7uj7Q-ZeelZoj_zjw#
> .
@prefix beldoc: <
http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix dce: <
http://purl.org/dc/elements/1.1/
> .
@prefix pav: <
http://purl.org/pav/
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix belv: <
http://www.selventa.com/vocabulary/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix hgnc: <
http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=
> .
@prefix proteinModification: <
http://www.ebi.ac.uk/ontology-lookup/?termId=MOD:00000
> .
@prefix mesh: <
http://purl.bioontology.org/ontology/MSH/
> .
@prefix atcc: <
http://www.lgcstandards-atcc.org/Products/All/
> .
@prefix occursIn: <
http://purl.obolibrary.org/obo/BFO_0000066
> .
@prefix species: <
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=
> .
@prefix pubmed: <
http://www.ncbi.nlm.nih.gov/pubmed/
> .
@prefix orcid: <
http://orcid.org/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:_1
belv:hasSubstitution
"R,273,H" ;
belv:variantOf
hgnc:11998
;
a
proteinModification:
.
sub:_2
occursIn:
atcc:HTB-38.aspx
,
species:9606
;
rdf:object
mesh:D017209
;
rdf:predicate
belv:decreases
;
rdf:subject
sub:_1
;
a
rdf:Statement
.
sub:assertion
rdfs:label
"p(HGNC:TP53,sub(R,273,H)) -| bp(MESHPP:Apoptosis)" .
}
sub:provenance
{
beldoc:
dce:description
"Approximately 61,000 statements." ;
dce:rights
"Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title
"BEL Framework Large Corpus Document" ;
pav:authoredBy
sub:_4
;
pav:version
"1.4" .
sub:_3
prov:value
"Results of these experiments revealed that, in all tested cell lines mp53 depletion allows a higher apoptotic response to drugs treatment, albeit to different extents (Figure 4b). These data confirm the notion that endogenous mp53 proteins contribute to chemoresistance of tumor cells." ;
prov:wasQuotedFrom
pubmed:16170357
.
sub:_4
rdfs:label
"Selventa" .
sub:assertion
prov:hadPrimarySource
pubmed:16170357
;
prov:wasDerivedFrom
beldoc:
,
sub:_3
.
}
sub:pubinfo
{
this:
dct:created
"2014-07-03T14:30:38.258+02:00"^^
xsd:dateTime
;
pav:createdBy
orcid:0000-0001-6818-334X
,
orcid:0000-0002-1267-0234
.
}